|
|
|
Volumn 25, Issue 4, 2000, Pages 196-202
|
|
Caution recommended for prescribing and administering COX 1/COX 2 and COX 2 specific NSAIDs
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
MELOXICAM;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
ROFECOXIB;
ALZHEIMER DISEASE;
AREA UNDER THE CURVE;
BLOOD TOXICITY;
DRUG BIOAVAILABILITY;
DRUG CONTRAINDICATION;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
GASTROINTESTINAL TOXICITY;
HUMAN;
LIVER TOXICITY;
LUNG TOXICITY;
MEDICAL DECISION MAKING;
NEPHROTOXICITY;
NEUROTOXICITY;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
PRESCRIPTION;
REVIEW;
RISK FACTOR;
|
|
EID: 0034005341
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (12)
|
|
References (87)
|
